KalVista announces FDA acceptance of New Drug Application for sebetralstat for oral on-demand treatment of hereditary angioedema KalVista...

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--Sep. 3, 2024-- KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the U.S....

Researchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, the virus that causes COVID-19, as well as distantly...

Perry had been seeking treatment for depression and anxiety when he became addicted to intravenous ketamine.

Perry had been seeking treatment for depression and anxiety when he became addicted to intravenous ketamine.

Car manufacturer Ford Motor Company has filed a patent application for an in-vehicle advertisement presentation system based on information derived...

CVRx announces the publication of positive study data for its Barostim therapy.